Anavotx
Leiden, NL · 25 employees on LinkedIn · 4 known investors
Find your way into Anavotx
Sign up to see every warm intro you have to Anavotx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Anavotx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Anavo Therapeutics is a biopharmaceutical company using its IGNITE platform to develop phosphatase-targeted allosteric modulators, addressing drug targets previously considered undruggable. It is building a proprietary pipeline of therapeutic programs targeting autoimmune diseases and cancer, with headquarters in Leiden, Netherlands and an R&D hub in Heidelberg, Germany.
Founders & leadership
Investors · 4
How we know: the company's own site · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Anavotx do?
- Anavo Therapeutics is a biopharmaceutical company using its IGNITE platform to develop phosphatase-targeted allosteric modulators, addressing drug targets previously considered undruggable. It is building a proprietary pipeline of therapeutic programs targeting autoimmune diseases and cancer, with headquarters in Leiden, Netherlands and an R&D hub in Heidelberg, Germany.
- Who are Anavotx's investors?
- Anavotx's investors include Taiho Ventures, LLC, Bioqube Ventures, Inkef, M Ventures.
- Where is Anavotx headquartered?
- Anavotx is headquartered in Leiden, NL.


